Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 408-412

  Kurokawa, Toshiro ^a   Kinoshita, Tomohiro ^a   Murate, Takashi ^a   Nagasaka, Tetsuro ^a   Kagami, Yoshitoyo ^b   Ogura, Michinori ^b   Nakamura, Shigeo ^b   Seto, Masao ^b   Hotta, Tomomitsu ^c   Saito, Hidehiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

CDR III; Mantle cell lymphoma; Minimal residual disease; PCR; RNase protection assay

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RIBONUCLEASE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME ASSAY; FEMALE; HUMAN; KARYOTYPE; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 8544254671     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2133030.x     Document Type: Article

References (27)

1. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. & Cardesa, A. (1994) PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84, 2726-2732.
2. Gribben, J.G., Freedman, A.S., Woo, S.D., Blake, K., Shu, R.S., Freeman, G., Longtine, J.A., Pinkus, G.S. & Nadler, L.M. (1991) All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood, 78, 3275-3280.
3. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De-Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
4. Hummel, M., Tamaru, J., Kalvelage, B. & Stein, H. (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood, 84, 403-407.
5. Kuroda, H., Komatsu, H., Nakamura, S., Niitsu, Y. Takahashi, T., Ueda, R. & Seto, M. (1995) The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Japanese Journal of Cancer Research, 86, 890-898.
6. Kurokawa, T., Kinoshita, T., Ito, T., Saito, H. & Hotta, T. (1996) Detection of minimal residual disease in B cell lymphoma by a PCR-mediated RNase protection assay. Leukemia, 10, 1222-1231.
7. Lee, M.S., Chang, K.S., Cabanillas, F., Freireich, E.J., Trujillo, J.M. & Stass, S.A. (1987) Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science, 237, 175-178.
8. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 1630-1636.
9. Luthra, R., Hai, S. & Pugh, W.C. (1995) Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagnostic Molecular Pathology, 4, 4-7.
10. Molot, R.J., Meeker, T.C., Wittwer, C.T., Perkins, S.L., Segal, G.H., Masih, A.S., Braylan, R.C. & Kjeldsberg, C.R. (1994) Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood, 83, 1626-1631.
11. Motokura, T., Bloom, T., Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M. & Arnold, A. (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature, 350, 512-515.
12. Nakamura, S., Seto, M., Banno, S., Suzuki, S., Koshikawa, T., Kitoh, K., Kagami, Y., Ogura, M., Yatabe, Y., Kojima, M., Motoori, T., Takahashi, T., Ueda, R. & Suchi, T. (1994) Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Japanese Journal of Cancer Research, 85, 1270-1279.
13. Norton, A.J., Matthews, J., Pappa, V., Shamash, J., Love, S., Rohatiner, A.Z.S. & Lister, T.A. (1995) Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Annals of Oncology, 6, 249-256.
14. Pittaluga, S., Wlodarska, I., Stul, M.S., Thomas, J., Verhoef, G., Cassiman, J.J., Van-den-Berghe, H. & De-Wolf-Peeters, C. (1995) Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathological, 26, 17-24.
15. Rimokh, R., Berger, F., Delsol, G., Charrin, C., Bertheas, M.F., Ffrench, M., Garoscio, M., Felman, P., Coiffier, B., Bryon, P.A., Rochet, M., Gentilhomme, O., Germain, D. & Magaud, J.P. (1993) Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood, 81, 3063-3067.
16. Rimokh, R., Berger, F., Delsol, G., Digonnet, I., Rouault, J.P., Tigaud, J.D., Gadoux, M., Coiffier, B., Bryon, P.A. & Magaud, J.P. (1994) Detection of the chromosomal translocation t(11:14) by polymerase chain reaction in mantle cell lymphomas. Blood, 83, 1871-1875.
17. Rosenberg, C.L., Wong, E., Petty, E.M., Bale, A.E., Tsujimoto, Y., Harris, N.L. & Arnold, A. (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Procroceedings of the National Academy of Sciences of the United States of America, 88, 9638-9642.
18. Segal, G.H., Masih, A.S., Fox, A.C., Jorgensen, T., Scott, M. & Braylan, R.C. (1995) CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood, 85, 1570-1579.
19. Seto, M., Yamamoto, K., Iida, S., Akao, Y., Utsumi, K.R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y., Namba, M., Motokura, T., Arnold, A., Takahashi, T. & Ueda, R. (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene, 7, 1401-1406.
20. Vandenberghe, E., De Wolf Peeters, C., Wlodarska, I., Stul, M., Louwagie, A., Verhoef, G., Thomas, J., Criel, A., Cassiman, J.J., Mecucci, C. & Van den Berghe, H. (1992) Chromosome 11q rearrangements in B non-Hodgkin's lymphoma. British Journal of Haematology, 81, 212-217.
21. Wasserman, R., Yamada, M., Ito, Y., Finger, L.R., Reichard, B.A., Shane, S., Lange, B. & Rovera, G. (1992) VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood, 79, 223-228.
22. Weisenburger, D.D. & Armitage, J.O. (1996) Mantle cell lymphoma: an entity comes of age. Blood, 87, 4483-4494.
23. Weisenburger, D.D., Sanger, W.G., Armitage, J.O. & Purtilo, D.T. (1987) Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic bindings. Blood, 69, 1617-1621.
24. Yang, W.I., Zukerberg, L.R., Motokura, T., Arnold, A. & Harris, N.L. (1994) Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. American Journal of Pathology, 145, 86-96.
25. Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., Ogura, M., Kojima, M., Koshikawa, T., Ueda, R. & Suchi, T. (1996) Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma, a distinct molecular pathologic entity. American Journal of Surgical Pathology, 20, 1110-1122.
26. Zucca, E., Roggero, E., Pinotti, G., Pedrinis, E., Cappella, C., Venco, A. & Cavalli, F. (1995) Patterns of survival in mantle cell lymphoma. Annals of Oncology, 6, 257-262.
27. Zucca, E., Stein, H. & Coiffier, B. (1994) European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL). Annals of Oncology, 5, 507-511.